Диссертация (1174358), страница 29
Текст из файла (страница 29)
– 2014. - 14(1). – P. 57–63.173272.Kim, SH. Simultaneous program of natural–cycle in vitro fertilization andcryopreserved–thawed embryo transfer. / SH. Kim, CH. Kim, CS. Suh et al //Journal of Assisted Reproduction and Genetics. – 1996. - 13(9). – P. 716–721.273.Klip, H. OMEGA Project Group. Risk of benign gynaecological diseases andhormonal disorders according to responsiveness to ovarian stimulation in IVF:a follow–up study of 8714 women / H. Klip // Human Reproduction. – 2003. 18(9). – P. 1951–1958.274.Kol, S. OHSS: yes, there is a strategy to prevent it! / S.
Kol, J. Itskovitz–Eldor// Human Reproduction. - 2000. – Vol. 15, № 11. – P. 2266–2267.275.Kolibianakis, EM. Addition of growth hormone to gonadotrophins in ovarianstimulation of poor responders treated by in–vitro fertilization: a systematicreview and meta–analysis. / EM. Kolibianakis, CA. Venetis, K. Diedrich et al //Human Reproduction. – 2009. - 15(6).
– P. 613–622.276.Kresowik, JD. Clinical factors associated with live birth after single embryotransfer. / JD. Kresowik, AE. Sparks, BJ. Van Voorhis // Fertility and Sterility.– 2012. - 98(5). – P. 1152–1156.277.Kristiansson, P. Tumour incidence in Swedish women who gave birthfollowing IVF treatment / P. Kristiansson // Human Reproduction. – 2007. 22(2). – P. 421–426.278.Ku, SY. Clinical efficacy of body mass index as predictor of in vitrofertilization and embryo transfer outcomes / SY.
Ku, SD. Kim, BC. Jee et al //Journal of Korean Medical Science. – 2006. - 11(2). – P. 300–303.279.Kumar, P. Ovarian hyperstimulation syndrome. Ovarian hyperstimulationsyndrome / P. Kumar // Human Reproduction. – 2011. - 4(2). – P. 70–75.280.Kumbak, B. Female obesity and assisted reproductive technologies / B.Kumbak // Seminars in Reproductive Medicine. - 2012. - 30(6). – P.
507–516.281.Kumbak, B. Impact of luteal phase hysteroscopy and concurrent endometrialbiopsy on subsequent IVF cycle outcome / B. Kumbak // Archives ofgynecology and obstetrics. - 2014 Mar 21.282.Kuwayama M. Highly efficient vitrification for cryopreservation of humanoocytes and embryos: the Cryotop method. / M. Kuwayama // Theriogenology.– 2007. - 67(1). – P. 73–80.283.La Marca, A. Anti–Mullerian hormone plasma levels in spontaneous menstrualcycle and during treatment with FSH to induce ovulation / A. La Marca, S.Malmusi, S.
Guillini et al // Human Reproduction. –2004. –vol.10. –№12. –pp.2738–2741.284.Lamazou, F. Serum AMH level is not a predictive value for IVF in modifiednatural cycle: analysis of 342 cycles. / F. Lamazou, V. Genro, F. Fuchs et al //Journal de Gynécologie Obstétrique et Biologie de la Reproduction. – 2011. 40(3). – P. 205–210.174285.Lamazou, F. Cancellation of IVF–ET cycles: poor prognosis, poor responder,or variability of the response to controlled ovarian hyperstimulation? Ananalysis of 142 cancellations / F. Lamazou // Journal de GynécologieObstétrique et Biologie de la Reproduction.
– 2012. - 41(1). – P. 41–47.286.Lawrenz, B. Premature progesterone rise in ART–cycles. / B. Lawrenz //Reproductive Biology and Endocrinology. – 2018. - 18(1). – P. 1–4.287.Lee, K.H. Comparison of clinical characteristics between early and latepatterns in hospitalized patients with ovarian hyperstimulation syndrome / K.H.Lee, S.H. Kim, B.C. Jee et al // Fertility and Sterility.
- 2009. -35. – P. 16-19.288.Lerner–Geva, L. The possible association between in vitro fertilizationtreatments and cancer development / L. Lerner-Geva // InternationalJournal of Gynecological Cancer. – 2003. - 13(1). – P. 23–27.289.Levy, M.J. The efficacy of natural versus stimulated cycle IVF–ET / M.J. Levy,P. Gindoff, J. Hall et al // Fertility and Sterility.
– 1996. - 56 (Suppl). – P. 15–16.290.Li, J. Natural cycle IVF/IVM may be more desirable for poor responderpatients after failure of stimulated cycles / J. Li, Y. Xu, G. Zhou et al // Journalof Assisted Reproduction and Genetics. – 2011. - 28(9). – P. 791–795.291.Lieberman B. An embryo too many?/ B. Lieberman // Human Reproduction.
1998. – 13. – P. 2664–2666.292.Lindheim, S.R. The significance of elevated early follicular–phase folliclestimulating hormone (FSH) levels: observations in unstimulated in vitrofertilization cycles / S.R. Lindheim, M.V. Sauer, M.M. Francis et al // Journalof Assisted Reproduction and Genetics. – 1996. – 13. – P. 49–52.293.Lindheim, SR. Poor responders to ovarian hyperstimulation may benefit froman attempt at natural–cycle oocyte retrieval. / SR.
Lindheim, A. Vidali, E.Ditkoff et al // Journal of Assisted Reproduction and Genetics. – 1997. - 14(3).– P. 174–176.294.Lucifero, D. Potential significance of genomic imprinting defects forreproduction and assisted reproductive technology / D. Lucifero, J.R. Chaillet,J.M. Trasler // Human Reproduction Update.
– 2004. - 10(1). – P. 3–18.295.MacDougall, MJ. Comparison of natural with clomiphene citrate–stimulatedcycles in in vitro fertilization: a prospective, randomized trial. / MJ.MacDougall, SL. Tan, V. Hall et al // Fertility and Sterility. – 1994. - 61(6). – P.1052–1057.296.Macklon, NS. Impact of ovarian hyperstimulation on the luteal phase / NS.Macklon, BC.
Fauser // Journal of reproduction and fertility. Supplement. 2000. – 55. – P. 101–108.175297.Mascarenhas, MN. National, regional, and global trends in infertilityprevalence since 1990: a systematic analysis of 277 health surveys / MN.Mascarenhas // PLoS Med. – 2012. - 9(12). - e1001356.298.Mathur, R. Review of the evidence base of strategies to prevent ovarianhyperstimulation syndrome / R. Mathur, C. Kailasam, J.
Jenkins // HumanFértility. - 2017. – Vol. 10, № 2. – P. 75–85.299.Matsuura, T. Natural IVF cycles may be desirable for women with repeatedfailures by stimulated IVF cycles / T. Matsuura // Journal of AssistedReproduction and Genetics. – 2013. - 25(4). – P. 163–167.300.Meldrum, DR. Successful pregnancies with unstimulated cycle oocyte donationusing an antagonist of gonadotropin–releasing hormone. / DR. Meldrum, J.Rivier, G. Garzo et al // Fertility and Sterility.
– 1994. - 61(3). – P. 556–557.301.Middeldorp, S. Pregnancy failure and heritable thrombophilia / S. Middeldorp// Semin Hematology. – 2007. – 44. – P. 93–97.302.Moragianni, VA. The effect of body mass index on the outcomes of firstassisted reproductive technology cycles / VA. Moragianni // Fertility andSterility. – 2012. - 98(1). – P. 102–108.303.Morgia, F. A controlled trial of natural cycle versus microdose gonadotropin–releasing hormone analog flare cycles in poor responders undergoing in vitrofertilization.
/ F. Morgia, M. Sbracia, M. Schimberni et al // Fertility andSterility. – 2004. - 81(6). – P. 1542–1547.304.Mukaida, T. Successful birth after transfer of vitrified human blastocysts withuse of a cryoloop containerless technique. / T. Mukaida, S. Nakamura, T.Tomiyama et al // Fertility and Sterility. – 2001. - 76(3).
– P. 618–620.305.Mullin, CM. Symptomatic isolated pleural effusion as an atypical presentation ofovarian hyperstimulation syndrome / CM. Mullin // Case Report Obstetrics andGynecology. – 2011. - doi: 10.1155/2011/967849.306.Murray, SR. Multiple pregnancies following assisted reproductive technologies– A happy consequence or double trouble? / SR. Murray, JE. Norman //Seminars in Fetal & Neonatal Medicine. - 2014.
– 18. – P. 12-18.307.Nargund, G. Natural–cycle/mild IVF: a science–based and patient–centeredapproach for the future / G. Nargund // Womens Health. – 2008. - 4(4). – P.327–328.308.Nargund, G. Cumulative conception and live birth rates in natural (unstimulated)IVF cycles / G. Nargund, J. Waterstone, J.M. Bland et al // HumanReproduction. – 2001. – 16. – P. 259–262.309.Nelson, S.M.The potential role of heparin in assisted conception / S.M. Nelson,I.A.
Greer // Human Reproduction Update. - 2014. - Vol. 14 (6). - P. 623–645.176310.Ng, EH. In vitro fertilization and embryo transfer during natural cycles. / EH.Ng, DK. Chui, OS. Tang et al // The Journal of Reproductive Medicine. – 2001.- 46(2). – P. 95–99.311.Ng, EH. Relationship between uterine blood flow and endometrial andsubendometrial blood flows during stimulated and natural cycles / EH. Ng, CC.Chan, OS. Tang et al // Fertility and Sterility.
– 2006. - 85(3). – P. 721–727.312.Nordengren, J. Differential localization and expression of urokinaseplasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI–1)mRNA and protein in endometrial tissue during the menstrual cycle / J.Nordengren, R. Pilka, V. Noskova et al // Human Reproduction.
– 2014. – 10. –P. 655–663.313.Oehninger S. Revealing the enigmas of implantation: what is the true impact ofovarian hyperstimulation? / S. Oehninger // Fertility and Sterility. – 2008. 89(1). – P. 27–30.314.Ombelet, W. Multiple gestation and infertility treatment: registration, reflectionand reaction–the Belgian project / W. Ombelet // Human Reproduction Update.– 2005. - 11(1). – P. 3–14.315.Omland, AK. Natural cycle IVF in unexplained, endometriosis–associated andtubal factor infertility / AK.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
